Estimated cumulative risks for pancreas and prostate cancer in BRCA2 mutation carriers by sex and age
| Age category (years) | Pancreas | Prostate | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | |||||||||||
| Risk * | 95% CI | Risk | 95% CI | Risk | 95% CI | |||||||
| *Cumulative risk as the probability of an individual being diagnosed with cancer by age t, conditional upon survival through all preceding age periods (%). | ||||||||||||
| <30 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 30–40 | 0 | 0 | 0 | 0 to 0.3 | 0 | 0 | ||||||
| 40–50 | 0.3 | 0 to 1.4 | 0.2 | 0 to 0.7 | 0.1 | 0 to 0.5 | ||||||
| 50–60 | 1.2 | 0 to 3.2 | 0.5 | 0 to 1.5 | 0.8 | 0 to 2.3 | ||||||
| 60–70 | 4.1 | 1.0 to 7.3 | 1.4 | 0 to 3.4 | 5.2 | 1.7 to 8.7 | ||||||
| 70–80 | 6.9 | 3.8 to 10 | 2.8 | 0.9 to 4.7 | 17.3 | 12.5 to 22 | ||||||